Cargando…
A review of outcome following valve surgery for rheumatic heart disease in Australia
BACKGROUND: Globally, rheumatic heart disease (RHD) remains an important cause of heart disease. In Australia it particularly affects younger Indigenous and older non-Indigenous Australians. Despite its impact there is limited understanding of the factors influencing outcome following surgery for RH...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580994/ https://www.ncbi.nlm.nih.gov/pubmed/26399240 http://dx.doi.org/10.1186/s12872-015-0094-1 |
_version_ | 1782391485731176448 |
---|---|
author | Russell, E. Anne Tran, Lavinia Baker, Robert A. Bennetts, Jayme S. Brown, Alex Reid, Christopher M. Tam, Robert Walsh, Warren F. Maguire, Graeme P. |
author_facet | Russell, E. Anne Tran, Lavinia Baker, Robert A. Bennetts, Jayme S. Brown, Alex Reid, Christopher M. Tam, Robert Walsh, Warren F. Maguire, Graeme P. |
author_sort | Russell, E. Anne |
collection | PubMed |
description | BACKGROUND: Globally, rheumatic heart disease (RHD) remains an important cause of heart disease. In Australia it particularly affects younger Indigenous and older non-Indigenous Australians. Despite its impact there is limited understanding of the factors influencing outcome following surgery for RHD. METHODS: The Australian and New Zealand Society of Cardiac and Thoracic Surgeons Cardiac Surgery Database was analysed to assess outcomes following surgical procedures for RHD and non-RHD valvular disease. The association with demographics, co-morbidities, pre-operative status, valve(s) affected and operative procedure was evaluated. RESULTS: Outcome of 1384 RHD and 15843 non-RHD valve procedures was analysed. RHD patients had longer ventilation, experienced fewer strokes and had more readmissions to hospital and anticoagulant complications. Mortality following RHD surgery at 30 days was 3.1 % (95 % CI 2.2 – 4.3), 5 years 15.3 % (11.7 – 19.5) and 10 years 25.0 % (10.7 – 44.9). Mortality following non-RHD surgery at 30 days was 4.3 % (95 % CI 3.9 - 4.6), 5 years 17.6 % (16.4 - 18.9) and 10 years 39.4 % (33.0 - 46.1). Factors independently associated with poorer longer term survival following RHD surgery included older age (OR1.03/additional year, 95 % CI 1.01 – 1.05), concomitant diabetes (OR 1.7, 95 % CI 1.1 – 2.5) and chronic kidney disease (1.9, 1.2 – 2.9), longer invasive ventilation time (OR 1.7 if greater than median value, 1.1– 2.9) and prolonged stay in hospital (1.02/additional day, 1.01 – 1.03). Survival in Indigenous Australians was comparable to that seen in non-Indigenous Australians. CONCLUSION: In a large prospective cohort study we have demonstrated survival following RHD valve surgery in Australia is comparable to earlier studies. Patients with diabetes and chronic kidney disease, were at particular risk of poorer long-term survival. Unlike earlier studies we did not find pre-existing atrial fibrillation, being an Indigenous Australian or the nature of the underlying valve lesion were independent predictors of survival. |
format | Online Article Text |
id | pubmed-4580994 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45809942015-09-25 A review of outcome following valve surgery for rheumatic heart disease in Australia Russell, E. Anne Tran, Lavinia Baker, Robert A. Bennetts, Jayme S. Brown, Alex Reid, Christopher M. Tam, Robert Walsh, Warren F. Maguire, Graeme P. BMC Cardiovasc Disord Research Article BACKGROUND: Globally, rheumatic heart disease (RHD) remains an important cause of heart disease. In Australia it particularly affects younger Indigenous and older non-Indigenous Australians. Despite its impact there is limited understanding of the factors influencing outcome following surgery for RHD. METHODS: The Australian and New Zealand Society of Cardiac and Thoracic Surgeons Cardiac Surgery Database was analysed to assess outcomes following surgical procedures for RHD and non-RHD valvular disease. The association with demographics, co-morbidities, pre-operative status, valve(s) affected and operative procedure was evaluated. RESULTS: Outcome of 1384 RHD and 15843 non-RHD valve procedures was analysed. RHD patients had longer ventilation, experienced fewer strokes and had more readmissions to hospital and anticoagulant complications. Mortality following RHD surgery at 30 days was 3.1 % (95 % CI 2.2 – 4.3), 5 years 15.3 % (11.7 – 19.5) and 10 years 25.0 % (10.7 – 44.9). Mortality following non-RHD surgery at 30 days was 4.3 % (95 % CI 3.9 - 4.6), 5 years 17.6 % (16.4 - 18.9) and 10 years 39.4 % (33.0 - 46.1). Factors independently associated with poorer longer term survival following RHD surgery included older age (OR1.03/additional year, 95 % CI 1.01 – 1.05), concomitant diabetes (OR 1.7, 95 % CI 1.1 – 2.5) and chronic kidney disease (1.9, 1.2 – 2.9), longer invasive ventilation time (OR 1.7 if greater than median value, 1.1– 2.9) and prolonged stay in hospital (1.02/additional day, 1.01 – 1.03). Survival in Indigenous Australians was comparable to that seen in non-Indigenous Australians. CONCLUSION: In a large prospective cohort study we have demonstrated survival following RHD valve surgery in Australia is comparable to earlier studies. Patients with diabetes and chronic kidney disease, were at particular risk of poorer long-term survival. Unlike earlier studies we did not find pre-existing atrial fibrillation, being an Indigenous Australian or the nature of the underlying valve lesion were independent predictors of survival. BioMed Central 2015-09-23 /pmc/articles/PMC4580994/ /pubmed/26399240 http://dx.doi.org/10.1186/s12872-015-0094-1 Text en © Russell et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Russell, E. Anne Tran, Lavinia Baker, Robert A. Bennetts, Jayme S. Brown, Alex Reid, Christopher M. Tam, Robert Walsh, Warren F. Maguire, Graeme P. A review of outcome following valve surgery for rheumatic heart disease in Australia |
title | A review of outcome following valve surgery for rheumatic heart disease in Australia |
title_full | A review of outcome following valve surgery for rheumatic heart disease in Australia |
title_fullStr | A review of outcome following valve surgery for rheumatic heart disease in Australia |
title_full_unstemmed | A review of outcome following valve surgery for rheumatic heart disease in Australia |
title_short | A review of outcome following valve surgery for rheumatic heart disease in Australia |
title_sort | review of outcome following valve surgery for rheumatic heart disease in australia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580994/ https://www.ncbi.nlm.nih.gov/pubmed/26399240 http://dx.doi.org/10.1186/s12872-015-0094-1 |
work_keys_str_mv | AT russelleanne areviewofoutcomefollowingvalvesurgeryforrheumaticheartdiseaseinaustralia AT tranlavinia areviewofoutcomefollowingvalvesurgeryforrheumaticheartdiseaseinaustralia AT bakerroberta areviewofoutcomefollowingvalvesurgeryforrheumaticheartdiseaseinaustralia AT bennettsjaymes areviewofoutcomefollowingvalvesurgeryforrheumaticheartdiseaseinaustralia AT brownalex areviewofoutcomefollowingvalvesurgeryforrheumaticheartdiseaseinaustralia AT reidchristopherm areviewofoutcomefollowingvalvesurgeryforrheumaticheartdiseaseinaustralia AT tamrobert areviewofoutcomefollowingvalvesurgeryforrheumaticheartdiseaseinaustralia AT walshwarrenf areviewofoutcomefollowingvalvesurgeryforrheumaticheartdiseaseinaustralia AT maguiregraemep areviewofoutcomefollowingvalvesurgeryforrheumaticheartdiseaseinaustralia AT russelleanne reviewofoutcomefollowingvalvesurgeryforrheumaticheartdiseaseinaustralia AT tranlavinia reviewofoutcomefollowingvalvesurgeryforrheumaticheartdiseaseinaustralia AT bakerroberta reviewofoutcomefollowingvalvesurgeryforrheumaticheartdiseaseinaustralia AT bennettsjaymes reviewofoutcomefollowingvalvesurgeryforrheumaticheartdiseaseinaustralia AT brownalex reviewofoutcomefollowingvalvesurgeryforrheumaticheartdiseaseinaustralia AT reidchristopherm reviewofoutcomefollowingvalvesurgeryforrheumaticheartdiseaseinaustralia AT tamrobert reviewofoutcomefollowingvalvesurgeryforrheumaticheartdiseaseinaustralia AT walshwarrenf reviewofoutcomefollowingvalvesurgeryforrheumaticheartdiseaseinaustralia AT maguiregraemep reviewofoutcomefollowingvalvesurgeryforrheumaticheartdiseaseinaustralia |